Hints and tips:
Related Special Reports
...That plan supports Beijing’s goals of chip self-sufficiency, with President Joe Biden’s administration tightening export restrictions for advanced chipmaking equipment in October, citing national security...
...Testing healthy people for single genes discovers useful health information about 2 per cent of the time, but polygenic risk scores can give helpful advice about 70 per cent of the time, according to the...
...Jones Bell is a clinical psychologist who has worked with adolescents and their families, and ran mental-health clinics on Stanford University’s campus for several years....
...Samsung’s $40bn investment into chipmaking in Texas announced on Monday includes a plan to build an “advanced chip packaging” facility, that will bring the US a big step closer to being able to manufacture...
...It is also the largest killer of 35- to 49-year-olds in the UK, according to the UK Health Security Agency....
...The government is set to publish details of a stricter regime for disability benefits. It is also rolling out local pilot schemes that integrate job and health support, branded “WorkWell”....
...The devices being created are not cleared for commercial use....
...: Reckitt: Shares in the health products maker advanced 4.5 per cent in early trading on better than expected sales in the first quarter, but it faces questions from shareholders over a US lawsuit concerning...
...The latest number was unchanged from the government’s forecast in January, dashing hopes of an earnings boost for companies servicing that segment....
...Scotland approved the drug for advanced cancer treatment in December, creating a “heartbreaking postcode lottery of access”, the charity said....
...Przybelski, at UW Health, said about half his patients were initially refused by Medicare Advantage plans for PET scan coverage, adding that “it normally involves a long phone call” to get scans approved...
...Patients on the donanemab study had more advanced Alzheimer’s than patients on similar studies, Eli Lilly said....
...In addition, the company said it was progressing towards US approval of an innovative cancer drug Datopotamab deruxtecan for the treatment of patients with advanced lung cancer....
...Soleno Therapeutics, a rival biotech which is expected to file for US Food and Drug Administration approval for another treatment for Prader-Willi syndrome later this year, is currently valued at nearly...
...I signed off the plan for Earth Day last week. Do you have any demands for Diabetes Week in June? God forbid we spend our time earning money. How about a Securing Revenue Awareness Day?...
...The answer lies in shorter-term practical wins the public can get behind, plus medium to longer-term plans for overdue change. More investment is unavoidable....
...Cuban is targeting the 38 per cent of private sector employers who self-insure at least one of their health plans....
...This meant A&E departments fell short of the interim target set out in the NHS recovery plan for 76 per cent of patients to be seen in four hours by March this year....
...However, David Rowland, chief executive of the Centre for Health and the Public Interest, a think-tank, said Labour’s plans were based on a “series of misunderstandings about the role the private sector...
...The Coalition for Epidemic Preparedness Innovations has longer-term plans to build production capacity in Senegal with the Institut Pasteur de Dakar....
...Crabb added that the Committee would investigate the “impact of metal mine pollution on human health, plans for remediation, the information available to the public, and whether existing regulations and...
...“Two years on from its [the government’s] long-awaited white paper ‘people at the heart of care’ — a 10-year ‘vision’ for adult social care — plans for reform have once again gone awry,” the MPs said....
...Last month, 23andMe announced that the first participant had been dosed in a Phase 1 clinical trial for an antibody that counters advanced solid tumours....
...Effective screening methods for early identification of dementia risk would enable the use of drugs that slow or even reverse its onset, greatly decreasing the costs for health systems....
...Bristol Myers Squibb is working on contingency plans to “protect the continuity of supply” of medicine in preparation for draft US legislation seeking to restrict Chinese pharmaceutical companies over national...
International Edition